Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet
- PMID: 20503448
- PMCID: PMC2877178
- DOI: 10.3748/wjg.v16.i20.2484
Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet
Abstract
Aim: To investigate whether semi-vegetarian diet (SVD) has a preventive effect against relapse of Crohn's disease (CD) in patients who have achieved remission, who are a high-risk group for relapse.
Methods: A prospective, single center, 2-year clinical trial was conducted. Twenty-two adult CD patients who achieved clinical remission either medically (n = 17) or surgically (n = 5) and consumed an SVD during hospitalization were advised to continue with an SVD and avoid known high-risk foods for inflammatory bowel disease. The primary endpoint was clinical relapse defined as the appearance of active symptoms of CD. Kaplan-Meier survival analysis was used to calculate the cumulative proportion of patients who had a relapse. A 2-year analysis of relapse rates of patients who followed an SVD and those who did not (an omnivorous diet group) was undertaken.
Results: SVD was continued by 16 patients (compliance 73%). Remission was maintained in 15 of 16 patients (94%) in the SVD group vs two of six (33%) in the omnivorous group. Remission rate with SVD was 100% at 1 year and 92% at 2 years. SVD showed significant prevention in the time to relapse compared to that in the omnivorous group (P = 0.0003, log rank test). The concentration of C-reactive protein was normal at the final visit in more than half of the patients in remission who were taking an SVD, who maintained remission during the study (9/15; 60%), who terminated follow-up (8/12; 67%), and who completed 2 years follow-up (7/10; 70%). There was no untoward effect of SVD.
Conclusion: SVD was highly effective in preventing relapse in CD.
Figures
Similar articles
-
Relapse-Free Course in Nearly Half of Crohn's Disease Patients With Infliximab and Plant-Based Diet as First-Line Therapy: A Single-Group Trial.Perm J. 2022 Jun 29;26(2):40-53. doi: 10.7812/TPP/21.073. Epub 2022 Jun 15. Perm J. 2022. PMID: 35933676 Free PMC article.
-
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.Gastroenterology. 2000 Feb;118(2):264-73. doi: 10.1016/s0016-5085(00)70208-3. Gastroenterology. 2000. PMID: 10648454 Clinical Trial.
-
Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease.Aliment Pharmacol Ther. 1997 Oct;11(5):845-52. doi: 10.1046/j.1365-2036.1997.00212.x. Aliment Pharmacol Ther. 1997. PMID: 9354191 Clinical Trial.
-
Review article: maintenance treatment of Crohn's disease.Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:31-7. doi: 10.1046/j.1365-2036.17.s2.20.x. Aliment Pharmacol Ther. 2003. PMID: 12786610 Review.
-
Current treatment for prevention of relapse and recurrence in Crohn's disease.Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):515-8. Ital J Gastroenterol Hepatol. 1999. PMID: 10575572 Review.
Cited by
-
Recent clinical evidence on nutrition, novel pharmacotherapy, and vaccination in inflammatory bowel diseases.Front Pharmacol. 2024 Sep 6;15:1380878. doi: 10.3389/fphar.2024.1380878. eCollection 2024. Front Pharmacol. 2024. PMID: 39308999 Free PMC article. Review.
-
Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease.United European Gastroenterol J. 2019 Jul;7(6):767-781. doi: 10.1177/2050640619841249. Epub 2019 Mar 27. United European Gastroenterol J. 2019. PMID: 31316781 Free PMC article.
-
Relapse Prevention in Ulcerative Colitis by Plant-Based Diet Through Educational Hospitalization: A Single-Group Trial.Perm J. 2018;22:17-167. doi: 10.7812/TPP/17-167. Perm J. 2018. PMID: 30005726 Free PMC article.
-
Mechanisms of Action of Exclusive Enteral Nutrition and Other Nutritional Therapies in Crohn's Disease.Nutrients. 2024 Oct 22;16(21):3581. doi: 10.3390/nu16213581. Nutrients. 2024. PMID: 39519414 Free PMC article. Review.
-
Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases.Nutrients. 2021 Mar 10;13(3):890. doi: 10.3390/nu13030890. Nutrients. 2021. PMID: 33801883 Free PMC article. Review.
References
-
- Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390–407. - PubMed
-
- Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology. 2007;133:1327–1339. - PubMed
-
- Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57:1185–1191. - PubMed
-
- Whelan G. Inflammatory bowel disease: epidemiology. In: Haubrich WS, Schaffner F, Berk JE, editors. Bockus Gastroenterology. 5th ed. Vol 2. Philadelphia: WB Saunders; 1995. pp. 1318–1325.
-
- Janssens AC, van Duijn CM. Genome-based prediction of common diseases: advances and prospects. Hum Mol Genet. 2008;17:R166–R173. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
